# Akebia Therapeutics Inc. (AKBA) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $236M |
| 2024 | $160M |
| 2023 | $195M |
| 2022 | $292M |
| 2021 | $212M |
| 2020 | $295M |
| 2019 | $335M |
| 2018 | $208M |
| 2017 | $181M |
| 2016 | $2M |
| 2015 | — |
| 2014 | — |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $54M |
| 2025-09-30 | $59M |
| 2025-06-30 | $62M |
| 2025-03-31 | $57M |
| 2024-09-30 | $37M |
| 2024-06-30 | $44M |
| 2024-03-31 | $33M |
| 2023-09-30 | $42M |
| 2023-06-30 | $56M |
| 2023-03-31 | $40M |
| 2022-09-30 | $49M |
| 2022-06-30 | $126M |
| 2022-03-31 | $62M |
| 2021-09-30 | $49M |
| 2021-06-30 | $53M |
| 2021-03-31 | $52M |
| 2020-09-30 | $60M |
| 2020-06-30 | $90M |
| 2020-03-31 | $88M |
| 2019-09-30 | $92M |
| 2019-06-30 | $101M |
| 2019-03-31 | $73M |
| 2018-09-30 | $53M |
| 2018-06-30 | $49M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AKBA/revenue)